Patient Advocates Are Partners, Not an Audience
Patient advocates are essential partners in advancing cancer research, yet new restrictions at major European medical congresses are limiting their access to industry discussions and exhibition spaces. WECAN warns that excluding patient representatives risks undermining collaboration, research priorities and patient involvement, calling for consistent regulations that protect meaningful participation. From WECAN Foundation…
